Come up with a name for your new list and we'll add to it:
ClostraBio raised a round of funding on June 01, 2017. Investors include
University of Chicago.
ClostraBio is discovering and developing new therapeutics that modulate the protective ability of the microbiome. It is developing a drug that can prevent allergic reactions to food.…